0	The pattern of PROTEIN binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger PROTEIN1PROTEIN2 binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger PROTEIN signaling .
0	The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN alpha helix and , in particular , on a triad of PROTEIN2 amino acids-Phe19 , Trp23 , and Leu26-which insert deep into the PROTEIN cleft .
0	The PROTEIN1 and PROTEIN2 receptors ( PROTEIN and PROTEIN , respectively ) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily .
0	PROTEIN associates with the PROTEIN1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/PROTEIN2 ligation .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN1PROTEIN2 ) and Fas ligand ( FasL/CD95L ) .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN ) -L ) and PROTEIN1 ( FasL/PROTEIN2 ) .
0	To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the interleukin 10 ( PROTEIN1PROTEIN2 , the STAT proteins activated by PROTEIN in different cell populations were first defined using electrophoretic mobility shift assays .
0	A potential interaction of PROTEIN and PROTEIN PROTEIN1PROTEIN2 PROTEIN receptors revealed by affinity crosslinking and immunoprecipitation .
1	We found that PROTEIN1 and PROTEIN2 can form a physical complex .
0	PROTEIN associates with the PROTEIN1 ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/PROTEIN2 ligation .
0	PROTEIN1 and its counter-receptor PROTEIN ligand ( PROTEIN ) are members of the TNF-receptor/PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 and the PROTEIN ( PROTEIN2 ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	Prompted by this hypothesis , we analyzed the genomic region containing the gene for MPIF-2/PROTEIN1 ( PROTEIN ) and have identified a novel CC chemokine termed PROTEIN2 .
0	Based on the experiences of all the authors , we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN and regulators of apoptosis such as PROTEIN1PROTEIN2 and PROTEIN and regulators of apoptosis such as PROTEIN and members of the PROTEIN family .
0	In certain cancers , PROTEIN1 amplification is a common event and contributes to the inactivation of PROTEIN2 .
0	PROTEIN associates with the T-cell receptor zeta chain ( PROTEIN1PROTEIN2 associates with the T-cell receptor zeta chain ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
1	Molecular determinants of the interaction between the C-terminal domain of Alzheimer 's PROTEIN1 and PROTEIN2 alpha-helices .
0	To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the PROTEIN1PROTEIN2 ( PROTEIN ) receptor , the STAT proteins activated by PROTEIN in different cell populations were first defined using electrophoretic mobility shift assays .
0	We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN or PROTEIN2 enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN did not require enzymatic activity .
0	If current models of chaperonin mechanism are correct , PROTEIN1 undergoes more rebinding and release cycles than does PROTEIN2 .
0	The genes for PROTEIN1/eotaxin-2 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) are localized within a region of approximately 40 kilobases .
0	In contrast , tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with PROTEIN or block PROTEIN1PROTEIN2 or block PROTEIN activation .
0	The binding properties of these variants in vitro , and the result of using a neutralizing monoclonal antibody directed against site 3 , lead to the conclusion that PROTEIN1 dimer is formed through direct binding at two independent and differently oriented sites on PROTEIN2 .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN ) -L ) and Fas ligand ( PROTEIN1/PROTEIN2 ) .
0	Based on the experiences of all the authors , we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN and regulators of apoptosis such as PROTEIN and members of the PROTEIN1PROTEIN2 and regulators of apoptosis such as PROTEIN and members of the PROTEIN family .
0	The POU domains of the PROTEIN1 and PROTEIN2 transcription factors mediate specific interaction with PROTEIN .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN1 ) -L ) and Fas ligand ( FasL/PROTEIN2 ) .
0	Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN1PROTEIN2 complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like PROTEIN1 , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN2 , utrophin/dystrophin related protein , and the Torpedo 87K protein .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( PROTEIN1PROTEIN2 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN1PROTEIN2 stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN1PROTEIN2 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
1	These data demonstrate that PROTEIN1 but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	The extracellular domain of the human neurotrophin PROTEIN1 receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for brain-derived neurotrophic factor ( PROTEIN2 ) .
0	The genes for MPIF-2/eotaxin-2 ( PROTEIN1 ) and PROTEIN2 ( PROTEIN ) are localized within a region of approximately 40 kilobases .
1	PROTEIN1 , a T cell activation Ag , also known as dipeptidyl peptidase IV , is directly associated with adenosine deaminase ( PROTEIN2 ) on the surface of T cells and T cell lines .
0	We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN or dipeptidyl peptidase IV enzymatic activity , indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity .
0	PROTEIN associates with the PROTEIN1PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
1	These data suggest that PROTEIN on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN1 binds to cell surface PROTEIN2 , and this complex is capable of reducing the local concentration of adenosine .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( PROTEIN1PROTEIN2 and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN2 enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN did not require enzymatic activity .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 , maintained PROTEIN binding equivalent to PROTEIN2 , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN .
0	Our results indicate that the PROTEIN and PROTEIN receptors can potentially interact , and that such an association may be responsible for the generation of high affinity PROTEIN1PROTEIN2 receptors can potentially interact , and that such an association may be responsible for the generation of high affinity PROTEIN binding sites .
1	The PROTEIN1 POU domain , which is highly homologous to the PROTEIN POU domain , likewise mediates interaction with PROTEIN2 .
0	We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN1 or dipeptidyl peptidase IV enzymatic activity , indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity .
0	PROTEIN1 also activated PROTEIN in Ba/F3 cells that stably expressed the murine PROTEIN2 .
0	We have therefore investigated whether the octamer binding proteins might physically interact with PROTEIN1 , the TATA box binding protein component of the PROTEIN2 factor .
0	We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN1 enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN2 did not require enzymatic activity .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN1/TR2 and PROTEIN2 , thereby suppressing LIGHT- mediated HT29 cell death .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( PROTEIN1 ) , PROTEIN2 ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	We demonstrate here that both the site 2 and site 3 PROTEIN variants complexed with IL-6R alpha bind a single PROTEIN1 molecule but are unable to dimerize it , whereas the combined site 2/3 variants lose the ability to interact with PROTEIN2 .
0	Further investigation indicated that the PROTEIN1/MyoD heterodimer bound to its specific DNA binding site in vitro , and the DNA binding was effectively blocked by PROTEIN2/HLH462 .
0	As expected , overexpression of either Id3/PROTEIN1 or PROTEIN2 effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
1	The potency of PROTEIN as a PROTEIN1 ligand seems , however , to be approximately 10-fold less than that of PROTEIN2 .
0	Although the individual amino acids in PROTEIN involved in binding to nerve growth factor ( PROTEIN1 ) and those in PROTEIN2 involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Additional analysis revealed the presence of transcripts for both the activating ( PROTEIN1 ) and inhibitory ( PROTEIN2 ) isoforms in differentiating C2C12 cultures , suggesting that both isoforms might participate in regulating the differentiation process .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 , maintained PROTEIN binding equivalent to PROTEIN , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN2 .
1	Evidence for physical interaction between the zinc-finger transcription factors PROTEIN1 and PROTEIN2 .
0	Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN2 complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
1	PROTEIN1 binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN2 , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
1	Here , we demonstrate that PROTEIN1 specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN ) -L ) and Fas ligand ( PROTEIN2/CD95L ) .
0	Comparisons with the hGH-hGHR complex reveal how PROTEIN1PROTEIN2 complex reveal how PROTEIN can bind to the two distinctly different receptor binding surfaces .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN1PROTEIN2 inhibits the interactions of PROTEIN with HVEM/TR2 and PROTEIN , thereby suppressing LIGHT- mediated HT29 cell death .
1	Physical and functional interactions between the transcriptional inhibitors PROTEIN1 and PROTEIN2 .
0	Thus , PROTEIN may play a regulatory role for suppressing in FasL- and PROTEIN1PROTEIN2 may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death .
0	PROTEIN associates with the PROTEIN1 ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2/CD3 ligation .
0	Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN1 complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN1 related protein , and the PROTEIN2 .
0	We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN or dipeptidyl peptidase IV enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN2 did not require enzymatic activity .
0	PROTEIN1 and its counter-receptor PROTEIN2 ligand ( PROTEIN ) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation .
0	We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN or dipeptidyl peptidase IV enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN2 did not require enzymatic activity .
0	By using several different experimental systems we show that PROTEIN efficiently associates with PROTEIN1 and PROTEIN2 .
0	To study the mechanism underlying the apparent functional cooperation between PROTEIN1 and PROTEIN2 , we explored the possibility of protein-protein interactions between these two transcription factors .
0	The human pituitary hormones , PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) , regulate a large variety of physiological processes , among which are growth and differentiation of muscle , bone and cartilage cells , and lactation .
1	PROTEIN1 and its counter-receptor PROTEIN ligand ( PROTEIN2 ) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation .
0	The helical cytokine PROTEIN1 and its specific binding subunit IL-6R alpha form a 1:1 complex which , by promoting homodimerization of the signalling subunit PROTEIN2 on the surface of target cells , triggers intracellular responses .
0	The PROTEIN POU domain , which is highly homologous to the PROTEIN1 POU domain , likewise mediates interaction with PROTEIN2 .
0	These data demonstrate that PROTEIN but not PROTEIN1PROTEIN2 but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
1	We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN transcription factor , PROTEIN1 , that interacts with the transcriptional inhibitor PROTEIN2/HLH462 .
0	We have therefore investigated whether the octamer binding proteins might physically interact with PROTEIN1 , the PROTEIN2 component of the PROTEIN factor .
0	Finally , we demonstrate that the anti-CD30L MAb M81 also completely inhibits PROTEIN1PROTEIN2 MAb M81 also completely inhibits CD30/CD30L interaction .
0	This information is useful for applying these MAbs in functional studies to further investigate the CD30/PROTEIN1PROTEIN2/CD30L system and for designing assays for soluble PROTEIN .
1	We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN or dipeptidyl peptidase IV enzymatic activity , indicating that the association between PROTEIN1 and PROTEIN2 did not require enzymatic activity .
0	The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN1PROTEIN2 bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix .
0	Therefore , we suggested that this fragment is implicated in the neurotoxicity of PROTEIN1 and in the protective effects of PROTEIN2 in Alzheimer 's disease .
0	Because cells lacking the protein tyrosine kinase PROTEIN are also defective in radiation-induced G1 arrest , we investigated the possibility that PROTEIN1PROTEIN2 are also defective in radiation-induced G1 arrest , we investigated the possibility that PROTEIN might interact with PROTEIN in response to radiation damage .
0	The PROTEIN and PROTEIN1 receptors ( PROTEIN2 and PROTEIN , respectively ) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily .
0	PROTEIN ( PROTEIN1 ( PROTEIN2 ) ) is a new member of the tumor necrosis factor receptor ( TNFR ) family .
0	Using a soluble CD30L/CD8alpha chimeric protein , we assessed the ability of anti-PROTEIN1 MAb to inhibit the binding of PROTEIN to PROTEIN2 expressed by the CD30+ Karpas 299 cell line .
0	As expected , overexpression of either Id3/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN1PROTEIN2 effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
1	Characterization of the PROTEIN1 binding domain on the human PROTEIN2 molecule using anti-CD30 antibodies .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta , transforming growth factors ( TGF ) beta1 and 2 , PROTEIN2 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN2 ) , the major cytoplasmic substrate of the PROTEIN receptor .
0	In addition , activation of PI 3-kinase was detected in anti-IRS-1 immunoprecipitates from gastrin-treated cells , suggesting that tyrosine phosphorylation of PROTEIN , which leads to the rapid recruitment of PROTEIN , might be one mechanism used by PROTEIN1 to activate PROTEIN2 .
0	PROTEIN does not bind to the PROTEIN receptor , but PROTEIN binds to both the PROTEIN1 and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap .
0	Using a soluble PROTEIN1/CD8alpha chimeric protein , we assessed the ability of anti-CD30 MAb to inhibit the binding of PROTEIN to PROTEIN2 expressed by the CD30+ Karpas 299 cell line .
0	Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 .
0	Co-transfection of human PROTEIN and PROTEIN1PROTEIN2 and PROTEIN expression vectors into B cells resulted in a synergistic activation of an octamer motif containing promoter .
1	In all cells tested , PROTEIN1 activated PROTEIN2 and PROTEIN and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors .
0	We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN or PROTEIN1 enzymatic activity , indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( PROTEIN1 ) and Fas ligand ( FasL/PROTEIN2 ) .
0	Further investigation indicated that the ITF-2b/MyoD heterodimer bound to its specific DNA binding site in vitro , and the DNA binding was effectively blocked by PROTEIN1/PROTEIN2 .
0	We further demonstrated that apolipoprotein E2 and E3 but not PROTEIN1PROTEIN2 and E3 but not apolipoprotein E4 can decrease the fusogenic activity of PROTEIN ( 29-42 ) via a direct interaction .
0	We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN or dipeptidyl peptidase IV enzymatic activity , indicating that the association between PROTEIN2 and PROTEIN did not require enzymatic activity .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN1PROTEIN2 or PROTEIN is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN2 complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	In this study , a minimum set of residues in the human PROTEIN second immunoglobulin-like domain , which does not bind PROTEIN1 ( PROTEIN2 ) , were substituted with those from human PROTEIN .
0	PROTEIN interaction with PROTEIN1PROTEIN2 PROTEIN represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate .
0	We have cloned and characterized human PROTEIN1 and a second isoform of human PROTEIN2 .
0	PROTEIN also activated PROTEIN1 in Ba/F3 cells that stably expressed the murine PROTEIN2 receptor .
0	As expected , overexpression of either Id3/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN1 promoter by the myogenic transcription factor PROTEIN2 .
0	Using a soluble CD30L/PROTEIN1 chimeric protein , we assessed the ability of anti-CD30 MAb to inhibit the binding of PROTEIN to PROTEIN2 expressed by the CD30+ Karpas 299 cell line .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with HVEM/TR2 and PROTEIN1 , thereby suppressing PROTEIN2- mediated HT29 cell death .
1	By using several different experimental systems we show that PROTEIN1 efficiently associates with PROTEIN and PROTEIN2 .
0	The genes for MPIF-2/PROTEIN1 ( PROTEIN ) and PROTEIN2 ( PROTEIN ) are localized within a region of approximately 40 kilobases .
0	PROTEIN1 does not bind to the PROTEIN2 receptor , but PROTEIN binds to both the PROTEIN and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	PROTEIN does not bind to the PROTEIN1 receptor , but PROTEIN binds to both the PROTEIN2 and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	PROTEIN interaction with PROTEIN represents a novel variant of a receptor-kinasPROTEIN1PROTEIN2 represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN1-Sos complex may contribute to the activation of the PROTEIN2 pathway by PROTEIN .
0	PROTEIN and its counter-receptor PROTEIN ligand ( PROTEIN1 ) are members of the TNF-receptor/PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation .
0	The rates of commitment to renaturation of PROTEIN1 and PROTEIN2 in the presence of the groE chaperonins .
0	We report here that PROTEIN also interacts with tyrosine-phosphorylated PROTEIN1 in response to PROTEIN2 .
0	In this study , a minimum set of residues in the human PROTEIN1 second immunoglobulin-like domain , which does not bind nerve growth factor ( PROTEIN2 ) , were substituted with those from human PROTEIN .
1	Although the individual amino acids in PROTEIN1 involved in binding to nerve growth factor ( PROTEIN2 ) and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	PROTEIN and its counter-receptor PROTEIN1 ( PROTEIN ) are members of the TNF-receptor/PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation .
0	Our results indicate that the PROTEIN and PROTEIN receptors can potentially interact , and that such an association may be responsible for the generation of high affinity PROTEIN1PROTEIN2 and PROTEIN receptors can potentially interact , and that such an association may be responsible for the generation of high affinity PROTEIN binding sites .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( PROTEIN1 ) and Fas ligand ( PROTEIN2/CD95L ) .
1	The PROTEIN1 oncoprotein is a cellular inhibitor of the PROTEIN2 tumor suppressor in that it can bind the transactivation domain of PROTEIN and downregulate its ability to activate transcription .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN , maintained PROTEIN1 binding equivalent to PROTEIN , and also bound PROTEIN2 , although with lower affinity compared with PROTEIN .
0	The interaction can also be observed in vivo , as PROTEIN1 can be co-precipitated with PROTEIN from co-transfected Cos1 cells and PROTEIN co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells .
0	The ability of PROTEIN1 to initiate transcription is augmented by the presence of a TATA motif or binding sites for transcription factor PROTEIN2 .
0	We demonstrate here that both the site 2 and site 3 PROTEIN variants complexed with PROTEIN1 bind a single PROTEIN molecule but are unable to dimerize it , whereas the combined site 2/3 variants lose the ability to interact with PROTEIN2 .
0	As expected , overexpression of either PROTEIN1/PROTEIN2 or PROTEIN effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
0	Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN with HVEM/TR2 and PROTEIN , thereby suppressing PROTEIN2- mediated HT29 cell death .
1	Collectively , PROTEIN1 is yet another functional ligand for PROTEIN2 .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN1 ( PROTEIN2 ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/PROTEIN1PROTEIN2 ( PROTEIN ) and HVEM/TR2 receptors .
0	Previously , we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ( PROTEIN1PROTEIN2 ( PROTEIN ) /eotaxin-2 to chromosome 7q11.23 ( Nomiyama , H. , Osborne , L. R. , Imai , T. , Kusuda , J. , Miura , R. , Tsui , L.-C. , and Yoshie , O .
0	The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN , maintained PROTEIN binding equivalent to PROTEIN , and also bound PROTEIN2 , although with lower affinity compared with PROTEIN .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1PROTEIN2 ( PROTEIN ) and the PROTEIN receptor ( IR ) with their two known substrates p52Shc and the PROTEIN receptor substrate-1 ( PROTEIN ) .
1	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1 receptor ( PROTEIN2 ) and HVEM/TR2 receptors .
1	Further investigation indicated that the PROTEIN1/PROTEIN2 heterodimer bound to its specific DNA binding site in vitro , and the DNA binding was effectively blocked by Id3/HLH462 .
1	PROTEIN1 , a T cell activation Ag , also known as dipeptidyl peptidase IV , is directly associated with PROTEIN2 ( PROTEIN ) on the surface of T cells and T cell lines .
0	PROTEIN also activated PROTEIN in Ba/F3 cells that stably expressed the murine PROTEIN1PROTEIN2 .
0	To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the interleukin 10 ( PROTEIN1 ) receptor , the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays .
0	Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN1 complexes with PROTEIN2-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	Following linkage studies which were most consistent with a beta spectrin gene mutation , a nucleotide change was identified in codon 2018 , resulting in an Ala -- > Gly substitution in the first helical domain of PROTEIN1PROTEIN2 gene mutation , a nucleotide change was identified in codon 2018 , resulting in an Ala -- > Gly substitution in the first helical domain of beta spectrin repeat 17 .
0	Using a soluble PROTEIN1/CD8alpha chimeric protein , we assessed the ability of anti-PROTEIN2 MAb to inhibit the binding of PROTEIN to PROTEIN expressed by the CD30+ Karpas 299 cell line .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with HVEM/PROTEIN1PROTEIN2 inhibits the interactions of PROTEIN with HVEM/TR2 and PROTEIN , thereby suppressing LIGHT- mediated HT29 cell death .
0	The genes for MPIF-2/PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) are localized within a region of approximately 40 kilobases .
0	PROTEIN associates with the PROTEIN1PROTEIN2 associates with the T-cell receptor zeta chain ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
0	Although the individual amino acids in PROTEIN involved in binding to PROTEIN1 ( PROTEIN ) and those in PROTEIN involved in binding to PROTEIN2 have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Cloning of the complete coding region for human PROTEIN1 using the two hybrid system and expression of PROTEIN2 in E. coli .
0	The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN , maintained PROTEIN binding equivalent to PROTEIN , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN2 .
1	Molecular cloning of a novel human CC chemokine ( PROTEIN1 ) that is a functional ligand of PROTEIN2 .
0	Coexpression of PROTEIN1 with PROTEIN2 in the baculovirus expression system resulted in the phosphorylation of PROTEIN on tyrosine residues .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of PROTEIN1PROTEIN2 regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN1 , utrophin/dystrophin related protein , and the PROTEIN2 .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN1PROTEIN2 ( PROTEIN ) and HVEM/TR2 receptors .
0	A newly identified member of tumor necrosis factor receptor superfamily ( PROTEIN1 ) suppresses PROTEIN2-mediated apoptosis .
0	In the present study , we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 receptor substrate 1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN receptor .
0	PROTEIN interaction with PROTEIN represents a novel variant of a receptor-kinasPROTEIN1PROTEIN2 PROTEIN represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PROTEIN1PROTEIN2 regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
1	PROTEIN1 interaction with PROTEIN2 represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 neurotrophin receptor and the PROTEIN2 , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN1PROTEIN2 with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
0	The extracellular domain of the human neurotrophin PROTEIN receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for PROTEIN1PROTEIN2 receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for brain-derived neurotrophic factor ( PROTEIN ) .
0	Because cells lacking the protein tyrosine kinase PROTEIN are also defective in radiation-induced G1 arrest , we investigated the possibility that PROTEIN might interact with PROTEIN1PROTEIN2 are also defective in radiation-induced G1 arrest , we investigated the possibility that PROTEIN might interact with PROTEIN in response to radiation damage .
0	Coexpression of PROTEIN with PROTEIN1 in the baculovirus expression system resulted in the phosphorylation of PROTEIN2 on tyrosine residues .
1	PROTEIN1 associates with the PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN1PROTEIN2 but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	Using immunoprecipitation techniques , we have determined the rates at which PROTEIN1 and glutamine synthetase ( PROTEIN2 ) are released from PROTEIN in a form committed to refold to active enzyme .
1	The PROTEIN1 oncoprotein is a cellular inhibitor of the PROTEIN tumor suppressor in that it can bind the transactivation domain of PROTEIN2 and downregulate its ability to activate transcription .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and PROTEIN1PROTEIN2 ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	Although the individual amino acids in PROTEIN1 involved in binding to nerve growth factor ( PROTEIN ) and those in PROTEIN involved in binding to PROTEIN2 have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Interactions between PROTEIN1 and the PROTEIN2 receptor .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and PROTEIN1PROTEIN2 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	Using immunoprecipitation techniques , we have determined the rates at which PROTEIN and PROTEIN1 ( PROTEIN2 ) are released from PROTEIN in a form committed to refold to active enzyme .
0	The human pituitary hormones , growth hormone ( PROTEIN1 ) and PROTEIN2 ( PROTEIN ) , regulate a large variety of physiological processes , among which are growth and differentiation of muscle , bone and cartilage cells , and lactation .
0	Coexpression of PROTEIN1 with PROTEIN in the baculovirus expression system resulted in the phosphorylation of PROTEIN2 on tyrosine residues .
1	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN , maintained PROTEIN1 binding equivalent to PROTEIN2 , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN .
0	These same PROTEIN1 residues are also involved in transactivation , supporting the hypothesis that PROTEIN inactivates PROTEIN2 by concealing its transactivation domain .
1	Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with HVEM/PROTEIN2 and PROTEIN , thereby suppressing LIGHT- mediated HT29 cell death .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN , maintained PROTEIN binding equivalent to PROTEIN1 , and also bound PROTEIN2 , although with lower affinity compared with PROTEIN .
0	The PROTEIN1 and PROTEIN receptors ( PROTEIN and PROTEIN2 , respectively ) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and PROTEIN1PROTEIN2 and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	More importantly , adenosine in the absence of cell surface PROTEIN inhibited T cell proliferation and PROTEIN1PROTEIN2 inhibited T cell proliferation and PROTEIN production induced by various stimuli .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN1 is directly recruited to the ligand-activated PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the Grb2-PROTEIN1 complex may contribute to the activation of the PROTEIN2 pathway by PROTEIN .
0	No binding between PROTEIN ( T ) and PROTEIN1PROTEIN2 ( T ) and PROTEIN was detected in T cells .
0	The genes for MPIF-2/eotaxin-2 ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ) are localized within a region of approximately 40 kilobases .
0	In keeping with this observation , we showed that human CD26-transfected murine pre-B cell lines lacking human PROTEIN1PROTEIN2-transfected murine pre-B cell lines lacking human PROTEIN acquired PROTEIN from an extracellular source .
1	PROTEIN1 binds independently to two transmembrane receptors , the PROTEIN2 and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
1	We found that PROTEIN1 was associated with PROTEIN2 on T cell lines lacking either PROTEIN or dipeptidyl peptidase IV enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN did not require enzymatic activity .
1	Here , we demonstrate that PROTEIN1 specifically binds two cellular ligands , PROTEIN ( PROTEIN2 ) and Fas ligand ( FasL/CD95L ) .
0	PROTEIN1 does not bind to the PROTEIN receptor , but PROTEIN binds to both the PROTEIN2 and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	Using a soluble PROTEIN1/CD8alpha chimeric protein , we assessed the ability of anti-CD30 MAb to inhibit the binding of PROTEIN2 to PROTEIN expressed by the CD30+ Karpas 299 cell line .
0	Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN2-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and PROTEIN1PROTEIN2 receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or PROTEIN1PROTEIN2 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or PROTEIN .
0	Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN1-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 .
0	PROTEIN interaction with PROTEIN represents a novel variant of a receptor-kinasPROTEIN1PROTEIN2 interaction with PROTEIN represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate .
0	PROTEIN associates with the T-cell receptor zeta chain ( PROTEIN1 ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2/CD3 ligation .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN1 , utrophin/PROTEIN2 related protein , and the Torpedo 87K protein .
0	PROTEIN1 associates with the T-cell receptor zeta chain ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/PROTEIN2 ligation .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN , PROTEIN2/dystrophin related protein , and the Torpedo 87K protein .
0	Although multimeric complexes of PROTEIN1 and PROTEIN2 were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	The recently cloned PROTEIN1 is such an PROTEIN2 .
0	The genes for MPIF-2/eotaxin-2 ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) are localized within a region of approximately 40 kilobases .
0	Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN1PROTEIN2 but not PROTEIN and blocked IL-10-induced PROTEIN phosphorylation in a cell-free system .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/PROTEIN1PROTEIN2/TR2 receptors .
0	We have therefore investigated whether the octamer binding proteins might physically interact with PROTEIN , the PROTEIN1 component of the PROTEIN2 factor .
0	Using the yeast two-hybrid system , a genetic assay for studying protein-protein interactions , we have examined and compared the interaction of the PROTEIN1 receptor ( PROTEIN2 ) and the PROTEIN receptor ( IR ) with their two known substrates p52Shc and the PROTEIN receptor substrate-1 ( PROTEIN ) .
0	We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN1 or PROTEIN2 enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN did not require enzymatic activity .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( PROTEIN1PROTEIN2 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
1	These results , obtained from a variety of experimental techniques , highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1 in binding PROTEIN2 .
0	The PROTEIN and PROTEIN receptors ( PROTEIN and PROTEIN1PROTEIN2 and PROTEIN , respectively ) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with HVEM/PROTEIN1PROTEIN2/TR2 and PROTEIN , thereby suppressing LIGHT- mediated HT29 cell death .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN1PROTEIN2 , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	Comparisons with the hGH-hGHR complex reveal how PROTEIN1PROTEIN2-hGHR complex reveal how PROTEIN can bind to the two distinctly different receptor binding surfaces .
0	The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN , maintained PROTEIN binding equivalent to PROTEIN2 , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN .
1	Finally , we demonstrate that the anti-CD30L MAb M81 also completely inhibits PROTEIN1/PROTEIN2 interaction .
0	The genes for PROTEIN1/eotaxin-2 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) are localized within a region of approximately 40 kilobases .
0	The genes for PROTEIN1/PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) are localized within a region of approximately 40 kilobases .
0	Moreover , using immunoelectron microscopy , we demonstrated that PROTEIN and PROTEIN1 co-localized on the cell surface , but not inside cells , suggesting that PROTEIN2 did not transport PROTEIN to the surface .
0	The deduced amino acid sequences of human alpha 1- and PROTEIN1 are nearly identical to their homologues in mouse , suggesting a strong functional conservation among the individual isoforms , Much like beta 1-syntrophin , human PROTEIN2 has multiple transcript classes and is expressed widely , although in a distinct pattern of relative abundance .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN1PROTEIN2 inhibits the interactions of PROTEIN with HVEM/TR2 and PROTEIN , thereby suppressing LIGHT- mediated HT29 cell death .
0	PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 substrate 1 and its association with PROTEIN and the phosphatidylinositol 3-kinase .
1	Here , we demonstrate that PROTEIN1 specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN ) -L ) and PROTEIN2 ( FasL/CD95L ) .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN1 ( herpes virus entry mediator ( PROTEIN ) -L ) and PROTEIN2 ( FasL/CD95L ) .
1	The physical interaction between PROTEIN1 and PROTEIN2 may thus form the basis for the functional interplay observed previously .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN1PROTEIN2 binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	The interaction can also be observed in vivo , as PROTEIN1 can be co-precipitated with PROTEIN from co-transfected Cos1 cells and PROTEIN2 co-immunoprecipitates with the endogenous PROTEIN from HeLa cells .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN2 related protein , and the Torpedo 87K protein .
0	Thus , PROTEIN may play a regulatory role for suppressing in PROTEIN1PROTEIN2 may play a regulatory role for suppressing in FasL- and LIGHT-mediated cell death .
1	Although the individual amino acids in PROTEIN1 involved in binding to PROTEIN2 ( PROTEIN ) and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 and the PROTEIN2 ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/PROTEIN1PROTEIN2 receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	In this study , we simulated interactions of all amphipathic helices of PROTEIN1 and A-I with PROTEIN2 and simian immunodeficiency virus ( SIV ) fusogenic fragments by molecular modeling .
0	We expressed differently tagged forms of PROTEIN1 and used them in solution-phase binding assays to show that the soluble extracellular domains of PROTEIN2 undergo dimerization in the absence of membranes .
0	Prompted by this hypothesis , we analyzed the genomic region containing the gene for PROTEIN1/eotaxin-2 ( PROTEIN2 ) and have identified a novel CC chemokine termed PROTEIN .
0	PROTEIN1 does not bind to the PROTEIN receptor , but PROTEIN binds to both the PROTEIN and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap .
0	We demonstrate here that both the site 2 and site 3 PROTEIN1 variants complexed with IL-6R alpha bind a single PROTEIN molecule but are unable to dimerize it , whereas the combined site 2/3 variants lose the ability to interact with PROTEIN2 .
0	Taken together , our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the gastrin/CCKB G protein-coupled receptor and the PROTEIN2 .
0	As expected , overexpression of either PROTEIN1/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN2 promoter by the myogenic transcription factor PROTEIN .
0	We found that PROTEIN was associated with PROTEIN on T cell lines lacking either PROTEIN1 or dipeptidyl peptidase IV enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN2 did not require enzymatic activity .
1	In addition , we identified domains within PROTEIN1 and PROTEIN2 that mediate their interactions with each other .
1	The interface relies on the steric complementarity between the PROTEIN cleft and the hydrophobic face of the PROTEIN alpha helix and , in particular , on a triad of PROTEIN1 amino acids-Phe19 , Trp23 , and Leu26-which insert deep into the PROTEIN2 cleft .
0	Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN1-receptor complexes with PROTEIN2-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	Evidence for a differential interaction of PROTEIN and the PROTEIN receptor substrate-1 ( PROTEIN ) with the PROTEIN1PROTEIN2 ( PROTEIN ) receptor in the yeast two-hybrid system .
0	The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN alpha helix and , in particular , on a triad of PROTEIN amino acids-Phe19 , Trp23 , and Leu26-which insert deep into the PROTEIN2 cleft .
0	The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN1PROTEIN2 revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix .
0	The human pituitary hormones , growth hormone ( PROTEIN ) and PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) , regulate a large variety of physiological processes , among which are growth and differentiation of muscle , bone and cartilage cells , and lactation .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 neurotrophin receptor and the PROTEIN ( PROTEIN2 ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the PROTEIN1 ( PROTEIN ) receptor , the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/PROTEIN1PROTEIN2 ) and HVEM/TR2 receptors .
0	We had previously shown that the ubiquitous PROTEIN1 and the lymphoid-specific PROTEIN2 transcription factors stimulate transcription at the level of stable preinitiation complex formation .
0	The deduced amino acid sequences of human alpha 1- and PROTEIN1 are nearly identical to their homologues in mouse , suggesting a strong functional conservation among the individual isoforms , Much like PROTEIN2 , human beta 2-syntrophin has multiple transcript classes and is expressed widely , although in a distinct pattern of relative abundance .
1	The extracellular domain of the human PROTEIN1 expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for brain-derived neurotrophic factor ( PROTEIN2 ) .
0	Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN2-receptor complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , PROTEIN1/PROTEIN2 related protein , and the Torpedo 87K protein .
0	We report here that PROTEIN1 also interacts with tyrosine-phosphorylated PROTEIN in response to PROTEIN2 .
1	The PROTEIN and PROTEIN1 receptors ( PROTEIN and PROTEIN2 , respectively ) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily .
0	Two distinct ligand binding domains of PROTEIN were isolated from proteolytic digests of the receptor by affinity separation on immobilized PROTEIN1PROTEIN2 were isolated from proteolytic digests of the receptor by affinity separation on immobilized PROTEIN .
0	The genes for MPIF-2/PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) are localized within a region of approximately 40 kilobases .
0	PROTEIN also activated PROTEIN1 in Ba/F3 cells that stably expressed the murine PROTEIN2 .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like PROTEIN1 , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , PROTEIN2/dystrophin related protein , and the Torpedo 87K protein .
0	A potential interaction of PROTEIN1 and PROTEIN PROTEIN2 receptors revealed by affinity crosslinking and immunoprecipitation .
0	The genes for PROTEIN1/eotaxin-2 ( PROTEIN ) and PROTEIN2 ( PROTEIN ) are localized within a region of approximately 40 kilobases .
1	These findings indicate that PROTEIN1 is involved in the activation of PROTEIN2 by DNA damage and this interaction may in part mediate radiation-induced G1 arrest .
0	As expected , overexpression of either Id3/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN1PROTEIN2 or PROTEIN effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
0	PROTEIN1 recruitment by two distinct ligand-induced , tyrosine-phosphorylated docking sites in the PROTEIN2 receptor intracellular domain .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with HVEM/PROTEIN1 and PROTEIN , thereby suppressing PROTEIN2- mediated HT29 cell death .
1	We further demonstrated that PROTEIN1 and E3 but not apolipoprotein E4 can decrease the fusogenic activity of PROTEIN2 ( 29-42 ) via a direct interaction .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and PROTEIN1PROTEIN2 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN1 ) , the major cytoplasmic substrate of the PROTEIN2 .
0	PROTEIN1 induced transient calcium mobilization specifically in PROTEIN2 ( PROTEIN ) -expressing L1.2 cells with an EC ( 50 ) of 3 nM .
0	In this study , a minimum set of residues in the human PROTEIN second immunoglobulin-like domain , which does not bind nerve growth factor ( PROTEIN ) , were substituted with those from human PROTEIN1PROTEIN2 ) , were substituted with those from human PROTEIN .
0	Taken together , our results suggest that PROTEIN1 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the gastrin/CCKB G protein-coupled receptor and the PROTEIN2 receptor .
0	To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the PROTEIN1 , the STAT proteins activated by PROTEIN2 in different cell populations were first defined using electrophoretic mobility shift assays .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN1 ( PROTEIN2 ) and Fas ligand ( FasL/CD95L ) .
0	Further investigation indicated that the ITF-2b/PROTEIN1 heterodimer bound to its specific DNA binding site in vitro , and the DNA binding was effectively blocked by Id3/PROTEIN2 .
0	Although the individual amino acids in PROTEIN involved in binding to PROTEIN1 ( PROTEIN ) and those in PROTEIN2 involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN complexes with trk-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 .
0	PROTEIN recruitment by two distinct ligand-induced , tyrosine-phosphorylated docking sites in the PROTEIN1PROTEIN2 receptor intracellular domain .
1	PROTEIN , a T cell activation Ag , also known as PROTEIN1 , is directly associated with PROTEIN2 ( PROTEIN ) on the surface of T cells and T cell lines .
1	Interaction between PROTEIN1 protein and PROTEIN2 in response to DNA damage .
0	Taken together , our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the PROTEIN1PROTEIN2 may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the gastrin/CCKB G protein-coupled receptor and the PROTEIN receptor .
1	These same PROTEIN residues are also involved in transactivation , supporting the hypothesis that PROTEIN1 inactivates PROTEIN2 by concealing its transactivation domain .
0	Evidence for a differential interaction of PROTEIN and the PROTEIN receptor substrate-1 ( PROTEIN ) with the PROTEIN1PROTEIN2 ) receptor in the yeast two-hybrid system .
0	The interface relies on the steric complementarity between the PROTEIN1 cleft and the hydrophobic face of the PROTEIN2 alpha helix and , in particular , on a triad of PROTEIN amino acids-Phe19 , Trp23 , and Leu26-which insert deep into the PROTEIN cleft .
0	Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN and blocked IL-10-induced PROTEIN1PROTEIN2-induced PROTEIN phosphorylation in a cell-free system .
1	The T-cell antigen PROTEIN1 acts as a receptor and substrate for the protein-tyrosine kinase PROTEIN2 .
1	Our results demonstrate that the SH3 domain of PROTEIN1 interacts with a DPAPNPPHFP motif ( residues 1,373-1,382 ) of PROTEIN2 .
0	Moreover , using immunoelectron microscopy , we demonstrated that PROTEIN and PROTEIN1 co-localized on the cell surface , but not inside cells , suggesting that PROTEIN did not transport PROTEIN2 to the surface .
0	On the other hand , cells expressing PROTEIN and PROTEIN1PROTEIN2 and PROTEIN on the surface were much more resistant to the inhibitory effect of adenosine .
1	The PROTEIN1 and PROTEIN receptors ( PROTEIN2 and PROTEIN , respectively ) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily .
0	The crystal structure of the human cyclinA-PROTEIN1 ( PROTEIN2 ) -ATP complex has been determined at 2.3 A resolution .
1	PROTEIN1 binding by PROTEIN2 is blocked by MAb that recognize epitopes belonging to cluster Group A ( like Ber-H2 , Ber-H8 , and HRS-4 ) as well as cluster Group C ( like HeFi-1 and M44 ) .
1	We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN transcription factor , PROTEIN1 , that interacts with the transcriptional inhibitor Id3/PROTEIN2 .
0	The pattern of PROTEIN binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger PROTEIN1PROTEIN2 MAb to trigger PROTEIN signaling .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , PROTEIN1/dystrophin related protein , and the PROTEIN2 .
0	Prompted by this hypothesis , we analyzed the genomic region containing the gene for PROTEIN1/eotaxin-2 ( PROTEIN ) and have identified a novel CC chemokine termed PROTEIN2 .
1	The crystal structure of the human PROTEIN1-cyclin-dependent kinase2 ( PROTEIN2 ) -ATP complex has been determined at 2.3 A resolution .
0	Activin A , a member of the PROTEIN1PROTEIN2 , a member of the PROTEIN superfamily , has various effects on diverse biological systems , including cell growth inhibition in many cell types .
0	Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of PROTEIN1PROTEIN2 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or PROTEIN .
0	PROTEIN1 associates with the T-cell receptor zeta chain ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2/CD3 ligation .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 , maintained PROTEIN2 binding equivalent to PROTEIN , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN .
0	Previously , we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ( PROTEIN ) /PROTEIN1PROTEIN2 ( PROTEIN ) /eotaxin-2 to chromosome 7q11.23 ( Nomiyama , H. , Osborne , L. R. , Imai , T. , Kusuda , J. , Miura , R. , Tsui , L.-C. , and Yoshie , O .
0	The helical cytokine interleukin ( IL ) 6 and its specific binding subunit PROTEIN1 form a 1:1 complex which , by promoting homodimerization of the signalling subunit PROTEIN2 on the surface of target cells , triggers intracellular responses .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with HVEM/TR2 and PROTEIN , thereby suppressing PROTEIN2- mediated HT29 cell death .
0	Based on the experiences of all the authors , we emphasized cell cycle inhibitors such as PROTEIN1 and PROTEIN2 and regulators of apoptosis such as PROTEIN and members of the PROTEIN family .
0	We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN transcription factor , PROTEIN , that interacts with the transcriptional inhibitor Id3/PROTEIN1PROTEIN2/HLH462 .
0	We further demonstrated that apolipoprotein E2 and E3 but not PROTEIN1 can decrease the fusogenic activity of PROTEIN2 ( 29-42 ) via a direct interaction .
0	The potency of PROTEIN as a PROTEIN ligand seems , however , to be approximately 10-fold less than that of PROTEIN1PROTEIN2 as a PROTEIN ligand seems , however , to be approximately 10-fold less than that of PROTEIN .
1	PROTEIN1 also activated PROTEIN2 in Ba/F3 cells that stably expressed the murine PROTEIN receptor .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1PROTEIN2 neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like PROTEIN1 , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN2 related protein , and the Torpedo 87K protein .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN1PROTEIN2 and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN1 ) -L ) and PROTEIN2 ( FasL/CD95L ) .
0	Evidence for a differential interaction of PROTEIN and the PROTEIN receptor substrate-1 ( PROTEIN ) with the PROTEIN1PROTEIN2 and the PROTEIN receptor substrate-1 ( PROTEIN ) with the insulin-like growth factor-I ( PROTEIN ) receptor in the yeast two-hybrid system .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like PROTEIN1 , both beta 2- and PROTEIN2 interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/dystrophin related protein , and the Torpedo 87K protein .
0	PROTEIN does not bind to the PROTEIN1 receptor , but PROTEIN2 binds to both the PROTEIN and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	PROTEIN1 induced transient calcium mobilization specifically in CC chemokine receptor 3 ( PROTEIN2 ) -expressing L1.2 cells with an EC ( 50 ) of 3 nM .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN1PROTEIN2 is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	Our data suggest that PROTEIN1 inhibits the interactions of PROTEIN with HVEM/TR2 and PROTEIN2 , thereby suppressing LIGHT- mediated HT29 cell death .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 .
0	Using a soluble CD30L/PROTEIN1 chimeric protein , we assessed the ability of anti-CD30 MAb to inhibit the binding of PROTEIN2 to PROTEIN expressed by the CD30+ Karpas 299 cell line .
0	Our results indicate that the PROTEIN and PROTEIN1PROTEIN2 and PROTEIN receptors can potentially interact , and that such an association may be responsible for the generation of high affinity PROTEIN binding sites .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like PROTEIN1 , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/dystrophin related protein , and the PROTEIN2 .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules PROTEIN1 and beta , PROTEIN2 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	A potential interaction of PROTEIN1 and PROTEIN2 PROTEIN receptors revealed by affinity crosslinking and immunoprecipitation .
0	PROTEIN1 and PROTEIN2 were chosen as substrates because they exhibit different solution requirements for the chaperonin system and they form stable `` folding arrested '' complexes with PROTEIN .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN1PROTEIN2 stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and PROTEIN1PROTEIN2 ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the PROTEIN1-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by PROTEIN2 .
0	Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN and blocked IL-10-induced PROTEIN1PROTEIN2 but not PROTEIN and blocked IL-10-induced PROTEIN phosphorylation in a cell-free system .
0	Characterization of the PROTEIN binding domain on the human PROTEIN molecule using anti-PROTEIN1PROTEIN2 molecule using anti-CD30 antibodies .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN ) -L ) and PROTEIN1 ( PROTEIN2/CD95L ) .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 ( PROTEIN2 ) , the major cytoplasmic substrate of the PROTEIN receptor .
0	Somatic cell hybrids and fluorescent in situ hybridization were both used to determine their chromosomal locations : PROTEIN1 to chromosome 16q22-23 and PROTEIN2 to chromosome 20q11.2 .
0	We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor , PROTEIN , that interacts with the transcriptional inhibitor Id3/PROTEIN2 .
0	Based on the experiences of all the authors , we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN and regulators of apoptosis such as PROTEIN1PROTEIN2 and regulators of apoptosis such as PROTEIN and members of the PROTEIN family .
0	The PROTEIN oncoprotein is a cellular inhibitor of the PROTEIN1 tumor suppressor in that it can bind the transactivation domain of PROTEIN2 and downregulate its ability to activate transcription .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1PROTEIN2 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN receptor .
0	As expected , overexpression of either PROTEIN1/HLH462 or PROTEIN2 effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
0	Further investigation indicated that the PROTEIN1/MyoD heterodimer bound to its specific DNA binding site in vitro , and the DNA binding was effectively blocked by Id3/PROTEIN2 .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and PROTEIN1PROTEIN2 ( PROTEIN ) and HVEM/TR2 receptors .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN1PROTEIN2 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	PROTEIN does not bind to the PROTEIN1 receptor , but PROTEIN binds to both the PROTEIN and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap .
0	As expected , overexpression of either Id3/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific PROTEIN1PROTEIN2 effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
0	The gene mutated in the autosomal recessive disorder ataxia telangiectasia ( AT ) , designated PROTEIN1 ( for 'PROTEIN2 ' ) , is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control , meiotic recombination , telomere length monitoring and DNA-damage response .
0	Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/PROTEIN1PROTEIN2/CD3 or PROTEIN .
0	The human pituitary hormones , PROTEIN1 ( PROTEIN ) and PROTEIN2 ( PROTEIN ) , regulate a large variety of physiological processes , among which are growth and differentiation of muscle , bone and cartilage cells , and lactation .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with HVEM/PROTEIN1 and PROTEIN2 , thereby suppressing LIGHT- mediated HT29 cell death .
0	The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN1PROTEIN2 revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix .
1	In all cells tested , PROTEIN1 activated PROTEIN and PROTEIN2 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN1PROTEIN2 or PROTEIN is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	PROTEIN competed the binding of ( 125 ) PROTEIN1PROTEIN2 competed the binding of ( 125 ) PROTEIN to CCR3-expressing L1.2 cells with an IC ( 50 ) of 13 nM .
1	Structure of the PROTEIN1 oncoprotein bound to the PROTEIN2 tumor suppressor transactivation domain .
1	Here , we demonstrate that PROTEIN1 specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN ) -L ) and Fas ligand ( FasL/PROTEIN2 ) .
0	Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN and blocked PROTEIN1PROTEIN2 but not PROTEIN and blocked IL-10-induced PROTEIN phosphorylation in a cell-free system .
0	PROTEIN1 does not bind to the PROTEIN receptor , but PROTEIN2 binds to both the PROTEIN and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	PROTEIN induced transient calcium mobilization specifically in PROTEIN1 ( PROTEIN2 ) -expressing L1.2 cells with an EC ( 50 ) of 3 nM .
0	In all cells tested , PROTEIN activated PROTEIN1 and PROTEIN2 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors .
1	The extracellular domain of the human PROTEIN1 expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for PROTEIN2 ( PROTEIN ) .
1	PROTEIN does not bind to the PROTEIN receptor , but PROTEIN1 binds to both the PROTEIN2 and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	PROTEIN ( PROTEIN1PROTEIN2 ( decoy receptor 3 ( PROTEIN ) ) is a new member of the tumor necrosis factor receptor ( TNFR ) family .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN1 ( herpes virus entry mediator ( PROTEIN ) -L ) and Fas ligand ( PROTEIN2/CD95L ) .
0	Moreover , using immunoelectron microscopy , we demonstrated that PROTEIN1 and PROTEIN2 co-localized on the cell surface , but not inside cells , suggesting that PROTEIN did not transport PROTEIN to the surface .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN1PROTEIN2 .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN1 ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 .
0	Moreover , using immunoelectron microscopy , we demonstrated that PROTEIN and PROTEIN co-localized on the cell surface , but not inside cells , suggesting that PROTEIN1 did not transport PROTEIN2 to the surface .
1	Here we show that PROTEIN1 binds PROTEIN2 constitutively in control cells but not in AT cells .
0	The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN , maintained PROTEIN2 binding equivalent to PROTEIN , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN .
1	The resulting Trk variant recruited binding of PROTEIN1 equivalent to PROTEIN2 , maintained PROTEIN binding equivalent to PROTEIN , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN .
0	PROTEIN does not bind to the PROTEIN receptor , but PROTEIN binds to both the PROTEIN and PROTEIN1 , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap .
0	Here , we demonstrate that PROTEIN1 specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN2 ) -L ) and Fas ligand ( FasL/CD95L ) .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN1PROTEIN2 triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	In this study , a minimum set of residues in the human PROTEIN1 second immunoglobulin-like domain , which does not bind nerve growth factor ( PROTEIN ) , were substituted with those from human PROTEIN2 .
0	Moreover , using immunoelectron microscopy , we demonstrated that PROTEIN1 and PROTEIN co-localized on the cell surface , but not inside cells , suggesting that PROTEIN2 did not transport PROTEIN to the surface .
0	Identification of PROTEIN1 will further promote our understanding of the control of eosinophil trafficking and other PROTEIN2-mediated biological phenomena .
0	Moreover , while PROTEIN1 inhibited the PROTEIN2 promoter , it acted as a weak transactivator on an artificial promoter consisting of three tandem copies of the consensus myogenic factor DNA binding site .
0	Thus , PROTEIN may play a regulatory role for suppressing in FasL- and PROTEIN1PROTEIN2- and LIGHT-mediated cell death .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN1PROTEIN2 , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN1PROTEIN2 ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN1PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
1	In the present study , we examined both the binding of PROTEIN1 and PROTEIN2 and the functional consequences of this interaction .
0	Based on the experiences of all the authors , we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN and regulators of apoptosis such as PROTEIN and members of the PROTEIN1PROTEIN2 and PROTEIN and regulators of apoptosis such as PROTEIN and members of the PROTEIN family .
1	Because cells lacking the protein tyrosine kinase PROTEIN are also defective in radiation-induced G1 arrest , we investigated the possibility that PROTEIN1 might interact with PROTEIN2 in response to radiation damage .
0	Although the individual amino acids in PROTEIN involved in binding to nerve growth factor ( PROTEIN ) and those in PROTEIN involved in binding to PROTEIN1PROTEIN2 ) and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	In this study , we demonstrate that PROTEIN is coupled to the protein-tyrosine kinase PROTEIN1 and can act as a substrate for PROTEIN2 .
0	The pattern of PROTEIN binding inhibition shows only limited correspondence to the functional capacity of some anti-PROTEIN1PROTEIN2 binding inhibition shows only limited correspondence to the functional capacity of some anti-CD30 MAb to trigger PROTEIN signaling .
0	Previously , we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ( PROTEIN1 ) /PROTEIN2 to chromosome 7q11.23 ( Nomiyama , H. , Osborne , L. R. , Imai , T. , Kusuda , J. , Miura , R. , Tsui , L.-C. , and Yoshie , O .
0	These data suggest that PROTEIN on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN binds to cell surface PROTEIN1PROTEIN2 on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN binds to cell surface PROTEIN , and this complex is capable of reducing the local concentration of adenosine .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN1 , PROTEIN2/dystrophin related protein , and the Torpedo 87K protein .
0	Taken together , our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the PROTEIN1/CCKB G protein-coupled receptor and the PROTEIN2 receptor .
0	Using a soluble CD30L/CD8alpha chimeric protein , we assessed the ability of anti-PROTEIN1 MAb to inhibit the binding of PROTEIN2 to PROTEIN expressed by the CD30+ Karpas 299 cell line .
0	PROTEIN and its counter-receptor PROTEIN ligand ( PROTEIN1PROTEIN2 ligand ( PROTEIN ) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation .
0	Finally , we demonstrate that the anti-CD30L MAb M81 also completely inhibits CD30/PROTEIN1PROTEIN2 MAb M81 also completely inhibits CD30/CD30L interaction .
0	These data suggest that PROTEIN on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN1PROTEIN2 on the cell surface is involved in an important immunoregulatory mechanism by which released PROTEIN binds to cell surface PROTEIN , and this complex is capable of reducing the local concentration of adenosine .
0	In the present study , we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN2 .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN , maintained PROTEIN1 binding equivalent to PROTEIN , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN2 .
0	The binding of PROTEIN to PROTEIN induced a 10- to 15-fold increase in PROTEIN1PROTEIN2 to PROTEIN induced a 10- to 15-fold increase in PROTEIN catalytic activity , as measured by in vitro kinase analysis .
0	PROTEIN ( decoy receptor 3 ( PROTEIN1PROTEIN2 ( decoy receptor 3 ( PROTEIN ) ) is a new member of the tumor necrosis factor receptor ( TNFR ) family .
0	PROTEIN associates with the T-cell receptor zeta chain ( PROTEIN1PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
1	Interactions between PROTEIN1 and the PROTEIN2 .
0	The conformers that are committed to the native state remained in the supernatant and were assayed after 1 h. At 25 degrees C , the rate profiles indicate the release and commitment to folding of PROTEIN1 to its native state occurs far earlier ( t1/2 < 1 min ) than for PROTEIN2 ( t1/2 = 5 min ) .
0	In contrast , the renaturation rate for PROTEIN1 with the groE chaperonins mirrored the committed renaturation rates following PROTEIN2 depletion .
1	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN , maintained PROTEIN binding equivalent to PROTEIN , and also bound PROTEIN1 , although with lower affinity compared with PROTEIN2 .
0	We found that PROTEIN was associated with PROTEIN1 on T cell lines lacking either PROTEIN2 or dipeptidyl peptidase IV enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN did not require enzymatic activity .
0	We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor , PROTEIN , that interacts with the transcriptional inhibitor PROTEIN2/HLH462 .
1	The interaction can also be observed in vivo , as PROTEIN1 can be co-precipitated with PROTEIN2 from co-transfected Cos1 cells and PROTEIN co-immunoprecipitates with the endogenous PROTEIN from HeLa cells .
0	Accordingly , a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors ( TNF ) alpha and beta , transforming growth factors ( TGF ) beta1 and 2 , PROTEIN1PROTEIN2 and 2 , interleukin ( IL ) 1 and its receptor antagonist ( IL 1ra ) , PROTEIN ( the receptor for lipopolysaccharide ) , P and E selectins , and platelet endothelial cell adhesion molecule ( PECAM ) 1 .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN2 .
0	The extracellular domain of the human neurotrophin PROTEIN receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for PROTEIN1 ( PROTEIN2 ) .
0	Interactions between brain-derived neurotrophic factor and the PROTEIN1PROTEIN2 receptor .
0	Here we have utilized affinity crosslinking agents with 125I-NGF to detect an association of PROTEIN1 and PROTEIN2 receptors in embryonic spinal cord and brain tissues enriched in the two receptors .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN , maintained PROTEIN binding equivalent to PROTEIN1 , and also bound brain-derived neurotrophin , although with lower affinity compared with PROTEIN2 .
0	PROTEIN1 binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN2 ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	PROTEIN1 binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN2 .
0	PROTEIN and its counter-receptor PROTEIN1 ligand ( PROTEIN ) are members of the TNF-receptor/PROTEIN2 superfamily and function to regulate lymphocyte survival and differentiation .
1	We show that the POU homeodomain of PROTEIN1 and the evolutionarily conserved C-terminal core domain of PROTEIN2 are both required and sufficient for the interaction .
0	Although the individual amino acids in PROTEIN1 involved in binding to nerve growth factor ( PROTEIN ) and those in PROTEIN2 involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Using a structure-function mutagenesis approach , two tyrosine residues ( Tyr427 and Tyr477 ) in the intracellular domain of the murine PROTEIN1 were found to be redundantly required for receptor function and for activation of PROTEIN but not for PROTEIN2 or PROTEIN .
0	The interaction can also be observed in vivo , as PROTEIN can be co-precipitated with PROTEIN1 from co-transfected Cos1 cells and PROTEIN co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells .
1	By using several different experimental systems we show that PROTEIN1 efficiently associates with PROTEIN2 and PROTEIN .
1	Here , we demonstrate that PROTEIN1 specifically binds two cellular ligands , PROTEIN2 ( herpes virus entry mediator ( PROTEIN ) -L ) and Fas ligand ( FasL/CD95L ) .
1	The potency of PROTEIN1 as a PROTEIN2 ligand seems , however , to be approximately 10-fold less than that of PROTEIN .
0	Prompted by this hypothesis , we analyzed the genomic region containing the gene for PROTEIN1/PROTEIN2 ( PROTEIN ) and have identified a novel CC chemokine termed PROTEIN .
0	PROTEIN1 binds independently to two transmembrane receptors , the PROTEIN2 neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	These results , obtained from a variety of experimental techniques , highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1PROTEIN2 in binding PROTEIN .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN1 ) , the major cytoplasmic substrate of the PROTEIN2 receptor .
1	Characterization of PROTEIN1 binding to human PROTEIN2 on T cells and its biologic role in immune response .
0	Based on the experiences of all the authors , we emphasized cell cycle inhibitors such as PROTEIN and PROTEIN and regulators of apoptosis such as PROTEIN1 and members of the PROTEIN2 family .
0	PROTEIN associates with the T-cell receptor zeta chain ( TcR zeta ) /PROTEIN1PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
1	The use of glutathione S-transferase-Lck fusion proteins in precipitation analysis showed that the SH2 domain of PROTEIN1 could recognize PROTEIN2 as expressed in the baculovirus expression system .
0	Using a soluble PROTEIN1/PROTEIN2 chimeric protein , we assessed the ability of anti-CD30 MAb to inhibit the binding of PROTEIN to PROTEIN expressed by the CD30+ Karpas 299 cell line .
0	PROTEIN1 also activated PROTEIN in Ba/F3 cells that stably expressed the murine PROTEIN2 receptor .
0	Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or PROTEIN1PROTEIN2/CD3 or PROTEIN .
1	PROTEIN , a T cell activation Ag , also known as PROTEIN1 , is directly associated with adenosine deaminase ( PROTEIN2 ) on the surface of T cells and T cell lines .
0	In keeping with this observation , we showed that human CD26-transfected murine pre-B cell lines lacking human PROTEIN acquired PROTEIN1PROTEIN2-transfected murine pre-B cell lines lacking human PROTEIN acquired PROTEIN from an extracellular source .
0	The deduced amino acid sequences of human alpha 1- and beta 2-syntrophin are nearly identical to their homologues in mouse , suggesting a strong functional conservation among the individual isoforms , Much like PROTEIN1 , human PROTEIN2 has multiple transcript classes and is expressed widely , although in a distinct pattern of relative abundance .
1	The POU domains of the PROTEIN and PROTEIN1 transcription factors mediate specific interaction with PROTEIN2 .
1	The crystal structure of the 109-residue amino-terminal domain of PROTEIN1 bound to a 15-residue transactivation domain peptide of PROTEIN2 revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix .
0	Taken together , our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the gastrin/PROTEIN1 G protein-coupled receptor and the PROTEIN2 receptor .
0	As expected , overexpression of either PROTEIN1/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN2 .
1	The interaction can also be observed in vivo , as PROTEIN can be co-precipitated with PROTEIN from co-transfected Cos1 cells and PROTEIN1 co-immunoprecipitates with the endogenous PROTEIN2 from HeLa cells .
1	PROTEIN does not bind to the PROTEIN receptor , but PROTEIN1 binds to both the PROTEIN and PROTEIN2 , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of PROTEIN1PROTEIN2 stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
0	Taken together , our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the gastrin/CCKB G protein-coupled receptor and the PROTEIN1PROTEIN2 receptor .
0	Using a soluble CD30L/PROTEIN1 chimeric protein , we assessed the ability of anti-PROTEIN2 MAb to inhibit the binding of PROTEIN to PROTEIN expressed by the CD30+ Karpas 299 cell line .
0	Further , anti-CD5 and anti-PROTEIN1PROTEIN2 and anti-p56lck coprecipitated each other in a variety of detergents , including Nonidet P-40 and Triton X-100 .
0	In keeping with this observation , we showed that human CD26-transfected murine pre-B cell lines lacking human PROTEIN acquired PROTEIN1PROTEIN2 acquired PROTEIN from an extracellular source .
0	Using a structure-function mutagenesis approach , two tyrosine residues ( Tyr427 and Tyr477 ) in the intracellular domain of the murine PROTEIN receptor were found to be redundantly required for receptor function and for activation of PROTEIN1 but not for PROTEIN2 or PROTEIN .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1PROTEIN2 receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and PROTEIN1PROTEIN2 triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	PROTEIN does not bind to the PROTEIN receptor , but PROTEIN1 binds to both the PROTEIN and PROTEIN , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN2 overlap .
1	The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN1 has a deep hydrophobic cleft on which the PROTEIN2 peptide binds as an amphipathic alpha helix .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN2 .
0	PROTEIN associates with the T-cell receptor zeta chain ( PROTEIN1 ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/PROTEIN2 ligation .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , PROTEIN1/PROTEIN2 , and the Torpedo 87K protein .
0	As expected , overexpression of either Id3/HLH462 or PROTEIN effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN1PROTEIN2 or PROTEIN effectively inhibited the activation of the muscle-specific creatine kinase promoter by the myogenic transcription factor PROTEIN .
0	PROTEIN associates with the T-cell receptor zeta chain ( TcR zeta ) /PROTEIN1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/PROTEIN2 ligation .
0	Although multimeric complexes of PROTEIN and PROTEIN1 were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN complexes with PROTEIN2-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1PROTEIN2 triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or PROTEIN1PROTEIN2 or PROTEIN .
0	The human pituitary hormones , PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) , regulate a large variety of physiological processes , among which are growth and differentiation of muscle , bone and cartilage cells , and lactation .
0	The binding of PROTEIN to PROTEIN induced a 10- to 15-fold increase in PROTEIN1PROTEIN2 induced a 10- to 15-fold increase in PROTEIN catalytic activity , as measured by in vitro kinase analysis .
0	The interaction can also be observed in vivo , as PROTEIN can be co-precipitated with PROTEIN1 from co-transfected Cos1 cells and PROTEIN2 co-immunoprecipitates with the endogenous PROTEIN from HeLa cells .
0	Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/PROTEIN1PROTEIN2 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or PROTEIN .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PROTEIN1PROTEIN2 stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PI 3-kinase ) .
0	These data demonstrate that PROTEIN but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN1PROTEIN2 but not PROTEIN or PROTEIN is directly recruited to the ligand-activated PROTEIN receptor by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	Using a structure-function mutagenesis approach , two tyrosine residues ( Tyr427 and Tyr477 ) in the intracellular domain of the murine PROTEIN1PROTEIN2 were found to be redundantly required for receptor function and for activation of PROTEIN but not for PROTEIN or PROTEIN .
0	Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN and blocked PROTEIN1PROTEIN2 and blocked IL-10-induced PROTEIN phosphorylation in a cell-free system .
0	The extracellular domain of the human PROTEIN1PROTEIN2 receptor expressed in Chinese hamster ovary cells is a highly glycosylated protein , possessing binding ability for brain-derived neurotrophic factor ( PROTEIN ) .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN1PROTEIN2 , and the Torpedo 87K protein .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by PROTEIN1PROTEIN2 pathway by PROTEIN .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN1PROTEIN2 neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	PROTEIN , a T cell activation Ag , also known as PROTEIN1PROTEIN2 , a T cell activation Ag , also known as dipeptidyl peptidase IV , is directly associated with adenosine deaminase ( PROTEIN ) on the surface of T cells and T cell lines .
0	Using immunoprecipitation techniques , we have determined the rates at which PROTEIN1 and PROTEIN2 ( PROTEIN ) are released from PROTEIN in a form committed to refold to active enzyme .
0	Characterization of the PROTEIN1 binding domain on the human PROTEIN molecule using anti-PROTEIN2 antibodies .
0	The human pituitary hormones , growth hormone ( PROTEIN ) and PROTEIN ( PROTEIN1PROTEIN2 ) and PROTEIN ( PROTEIN ) , regulate a large variety of physiological processes , among which are growth and differentiation of muscle , bone and cartilage cells , and lactation .
0	Following PROTEIN stimulation , we observed a time- and dose-dependent association of PROTEIN with the PROTEIN regulatory subunit of phosphatidylinositol 3-kinase ( PROTEIN1PROTEIN2 ( PI 3-kinase ) .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/dystrophin related protein , and the PROTEIN2 .
1	Although the individual amino acids in PROTEIN involved in binding to nerve growth factor ( PROTEIN ) and those in PROTEIN1 involved in binding to PROTEIN2 have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN1 ( herpes virus entry mediator ( PROTEIN2 ) -L ) and Fas ligand ( FasL/CD95L ) .
0	PROTEIN does not bind to the PROTEIN receptor , but PROTEIN binds to both the PROTEIN1 and PROTEIN2 , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( herpes virus entry mediator ( PROTEIN1 ) -L ) and Fas ligand ( PROTEIN2/CD95L ) .
0	In this study , a minimum set of residues in the human PROTEIN second immunoglobulin-like domain , which does not bind nerve growth factor ( PROTEIN ) , were substituted with those from human PROTEIN1PROTEIN2 ( PROTEIN ) , were substituted with those from human PROTEIN .
0	We found that PROTEIN1 was associated with PROTEIN on T cell lines lacking either PROTEIN2 or dipeptidyl peptidase IV enzymatic activity , indicating that the association between dipeptidyl peptidase IV and PROTEIN did not require enzymatic activity .
0	PROTEIN and its counter-receptor PROTEIN1 ( PROTEIN2 ) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation .
1	Mechanism of CDK activation revealed by the structure of a PROTEIN1-PROTEIN2 complex .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN2 , utrophin/dystrophin related protein , and the Torpedo 87K protein .
0	In the present study , we demonstrate that PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN receptor substrate 1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN2 receptor .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN neurotrophin receptor and the PROTEIN ( PROTEIN ) tyrosine kinase receptor , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN1PROTEIN2 , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	PROTEIN and its counter-receptor PROTEIN1PROTEIN2 ligand ( PROTEIN ) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the Grb2-Sos complex may contribute to the activation of the PROTEIN1PROTEIN2 and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by PROTEIN .
0	PROTEIN1 stimulates tyrosine phosphorylation of PROTEIN2 receptor substrate 1 and its association with PROTEIN and the phosphatidylinositol 3-kinase .
0	Moreover , using immunoelectron microscopy , we demonstrated that PROTEIN1 and PROTEIN co-localized on the cell surface , but not inside cells , suggesting that PROTEIN did not transport PROTEIN2 to the surface .
0	Although multimeric complexes of PROTEIN1 and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN complexes with PROTEIN2-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN .
1	PROTEIN1 and its counter-receptor PROTEIN2 ( PROTEIN ) are members of the TNF-receptor/TNFalpha superfamily and function to regulate lymphocyte survival and differentiation .
0	PROTEIN associates with the T-cell receptor zeta chain ( TcR zeta ) /PROTEIN1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2/CD3 ligation .
0	The interface relies on the steric complementarity between the PROTEIN cleft and the hydrophobic face of the PROTEIN1 alpha helix and , in particular , on a triad of PROTEIN amino acids-Phe19 , Trp23 , and Leu26-which insert deep into the PROTEIN2 cleft .
0	The PROTEIN1 POU domain , which is highly homologous to the PROTEIN2 POU domain , likewise mediates interaction with PROTEIN .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and PROTEIN1 interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN2 , and the Torpedo 87K protein .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the Grb2-PROTEIN1 complex may contribute to the activation of the mitogen-activated protein kinase pathway by PROTEIN2 .
0	These data demonstrate that PROTEIN but not PROTEIN1 or PROTEIN is directly recruited to the ligand-activated PROTEIN2 by binding to specific but redundant receptor intracellular domain sequences containing phosphotyrosine .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and PROTEIN1PROTEIN2 ) and HVEM/TR2 receptors .
1	Using a structure-function mutagenesis approach , two tyrosine residues ( Tyr427 and Tyr477 ) in the intracellular domain of the murine PROTEIN1 were found to be redundantly required for receptor function and for activation of PROTEIN2 but not for PROTEIN or PROTEIN .
0	The novel fold of the TNF receptor structure is likely to be representative of the nerve growth factor ( PROTEIN1PROTEIN2 ( PROTEIN ) /TNF receptor family as a whole .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN1 , utrophin/PROTEIN2 , and the Torpedo 87K protein .
1	PROTEIN1 competed the binding of ( 125 ) PROTEIN to PROTEIN2-expressing L1.2 cells with an IC ( 50 ) of 13 nM .
0	PROTEIN1 associates with the T-cell receptor zeta chain ( TcR zeta ) /PROTEIN2 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
0	Prompted by this hypothesis , we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 ( PROTEIN1 ) and have identified a novel CC chemokine termed PROTEIN2 .
0	This information is useful for applying these MAbs in functional studies to further investigate the CD30/CD30L system and for designing assays for soluble PROTEIN1PROTEIN2 system and for designing assays for soluble PROTEIN .
0	Nerve growth factor binds independently to two transmembrane receptors , the PROTEIN1 and the PROTEIN2 , which are both co-expressed in the majority of neuronal cells that respond to PROTEIN .
0	PROTEIN1 does not bind to the PROTEIN receptor , but PROTEIN binds to both the PROTEIN and PROTEIN2 , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	We have previously reported that tyrosine phosphorylation of PROTEIN and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by PROTEIN1PROTEIN2 and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by PROTEIN .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/PROTEIN1PROTEIN2 triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/TR2 receptors .
1	The self-association site appears to be formed by interactions between helices 1 and 2 of PROTEIN1 repeat 17 of one dimer with helix 3 of PROTEIN2 repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments .
1	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like PROTEIN1 , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN2 , and the Torpedo 87K protein .
0	Taken together , our results suggest that PROTEIN may serve as a converging target in the signaling pathways stimulated by receptors that belong to different families , such as the PROTEIN1/CCKB G protein-coupled receptor and the PROTEIN2 .
0	The interface relies on the steric complementarity between the PROTEIN cleft and the hydrophobic face of the PROTEIN1 alpha helix and , in particular , on a triad of PROTEIN2 amino acids-Phe19 , Trp23 , and Leu26-which insert deep into the PROTEIN cleft .
1	Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with HVEM/TR2 and PROTEIN2 , thereby suppressing LIGHT- mediated HT29 cell death .
0	Further investigation indicated that the ITF-2b/PROTEIN1 heterodimer bound to its specific DNA binding site in vitro , and the DNA binding was effectively blocked by PROTEIN2/HLH462 .
0	It has been shown that PROTEIN triggers apoptosis of various tumor cells including HT29 cells that express both PROTEIN1PROTEIN2 triggers apoptosis of various tumor cells including HT29 cells that express both lymphotoxin beta receptor ( PROTEIN ) and HVEM/TR2 receptors .
0	PROTEIN associates with the PROTEIN1 ( PROTEIN2 ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of TcR zeta/CD3 ligation .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 receptor substrate 1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN2 receptor .
0	Prompted by this hypothesis , we analyzed the genomic region containing the gene for MPIF-2/PROTEIN1 ( PROTEIN2 ) and have identified a novel CC chemokine termed PROTEIN .
0	PROTEIN stimulates tyrosine phosphorylation of PROTEIN1PROTEIN2 receptor substrate 1 and its association with PROTEIN and the phosphatidylinositol 3-kinase .
0	In the present study , we demonstrate that PROTEIN stimulates tyrosine phosphorylation of PROTEIN1 ( PROTEIN ) , the major cytoplasmic substrate of the PROTEIN2 receptor .
1	We present here the crystal structure of the 1:1 complex of PROTEIN1 bound to the extracellular domain of the PROTEIN2 .
1	Using a soluble CD30L/CD8alpha chimeric protein , we assessed the ability of anti-CD30 MAb to inhibit the binding of PROTEIN1 to PROTEIN2 expressed by the CD30+ Karpas 299 cell line .
0	Although multimeric complexes of PROTEIN and PROTEIN were not detected by affinity crosslinking , immunoprecipitation of cross-linked PROTEIN complexes with PROTEIN1-specific antibodies resulted in selective immunoprecipitation of crosslinked PROTEIN2 .
0	PROTEIN associates with the T-cell receptor zeta chain ( TcR zeta ) /CD3 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN1/PROTEIN2 ligation .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN1 ( herpes virus entry mediator ( PROTEIN ) -L ) and Fas ligand ( FasL/PROTEIN2 ) .
0	Using a structure-function mutagenesis approach , two tyrosine residues ( Tyr427 and Tyr477 ) in the intracellular domain of the murine PROTEIN1 receptor were found to be redundantly required for receptor function and for activation of PROTEIN but not for PROTEIN2 or PROTEIN .
0	In this study , a minimum set of residues in the human PROTEIN1 second immunoglobulin-like domain , which does not bind PROTEIN2 ( PROTEIN ) , were substituted with those from human PROTEIN .
0	Although the individual amino acids in PROTEIN involved in binding to PROTEIN1 ( PROTEIN2 ) and those in PROTEIN involved in binding to PROTEIN have been mapped in this domain , the Trk amino acids that provide specificity remained unclear .
1	Cluster Group B antibodies , including M67 and Ki-1 , do not affect PROTEIN1 binding to PROTEIN2 .
0	PROTEIN1 interaction wPROTEIN2 PROTEIN represents a novel variant of a receptor-kinase complex in which receptor can also serve as substrate .
0	PROTEIN does not bind to the PROTEIN1 receptor , but PROTEIN binds to both the PROTEIN and PROTEIN2 , and mutagenesis studies have shown that the receptor-binding sites on PROTEIN overlap .
0	Twelve amino acid peptides encompassing either of these two tyrosine residues in phosphorylated form coprecipitated PROTEIN but not PROTEIN and blocked IL-10-induced PROTEIN1PROTEIN2 and blocked IL-10-induced PROTEIN phosphorylation in a cell-free system .
0	Finally , we used in vitro translated proteins in an immunoprecipitation assay to show that , like beta 1-syntrophin , both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of PROTEIN , utrophin/PROTEIN1 , and the PROTEIN2 .
0	Using a structure-function mutagenesis approach , two tyrosine residues ( Tyr427 and Tyr477 ) in the intracellular domain of the murine PROTEIN1 receptor were found to be redundantly required for receptor function and for activation of PROTEIN2 but not for PROTEIN or PROTEIN .
1	Comparisons with the PROTEIN1-PROTEIN2 complex reveal how PROTEIN can bind to the two distinctly different receptor binding surfaces .
0	The X-ray structure of a PROTEIN1-PROTEIN2 receptor complex .
0	In a previous work , we predicted and demonstrated that the 29-42-residue fragment of PROTEIN1 ( PROTEIN2 ) has in vitro capacities close to those of the tilted fragment of viral fusion proteins .
0	The crystal structure of the 109-residue amino-terminal domain of PROTEIN bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN1PROTEIN2 bound to a 15-residue transactivation domain peptide of PROTEIN revealed that PROTEIN has a deep hydrophobic cleft on which the PROTEIN peptide binds as an amphipathic alpha helix .
0	PROTEIN1 inhibited PROTEIN2-induced cytotoxicity in HT29 cells .
0	This information is useful for applying these MAbs in functional studies to further investigate the CD30/CD30L system and for designing assays for soluble PROTEIN1PROTEIN2/CD30L system and for designing assays for soluble PROTEIN .
0	To define the mechanism underlying signal transducer and activator of transcription ( STAT ) protein recruitment to the interleukin 10 ( PROTEIN1PROTEIN2 ( PROTEIN ) receptor , the STAT proteins activated by PROTEIN in different cell populations were first defined using electrophoretic mobility shift assays .
1	Our data suggest that PROTEIN inhibits the interactions of PROTEIN1 with PROTEIN2/TR2 and PROTEIN , thereby suppressing LIGHT- mediated HT29 cell death .
1	The POU domains of the PROTEIN1 and PROTEIN transcription factors mediate specific interaction with PROTEIN2 .
0	Here , we demonstrate that PROTEIN specifically binds two cellular ligands , PROTEIN ( PROTEIN1 ) and PROTEIN2 ( FasL/CD95L ) .
0	These same PROTEIN1 residues are also involved in transactivation , supporting the hypothesis that PROTEIN2 inactivates PROTEIN by concealing its transactivation domain .
0	Our data suggest that PROTEIN inhibits the interactions of PROTEIN with PROTEIN1/TR2 and PROTEIN , thereby suppressing PROTEIN2- mediated HT29 cell death .
1	PROTEIN competed the binding of ( 125 ) PROTEIN1 to PROTEIN2-expressing L1.2 cells with an IC ( 50 ) of 13 nM .
0	PROTEIN associates with the PROTEIN1 complex and is rapidly phosphosphorylated on tyrosine residues as a result of PROTEIN2/CD3 ligation .
0	PROTEIN , a T cell activation Ag , also known as dipeptidyl peptidase IV , is directly associated with adenosine deaminase ( PROTEIN1PROTEIN2 ( PROTEIN ) on the surface of T cells and T cell lines .
0	These results , obtained from a variety of experimental techniques , highlight the importance of two distinct regions of the extracellular domain of the PROTEIN1 receptor in binding PROTEIN2 .
1	The crystal structure of the human PROTEIN1-PROTEIN2 ( PROTEIN ) -ATP complex has been determined at 2.3 A resolution .
0	The resulting Trk variant recruited binding of PROTEIN equivalent to PROTEIN1 , maintained PROTEIN binding equivalent to PROTEIN , and also bound PROTEIN2 , although with lower affinity compared with PROTEIN .
0	We have used an interaction cloning strategy to identify an inhibitory isoform of the PROTEIN1 transcription factor , PROTEIN2 , that interacts with the transcriptional inhibitor Id3/HLH462 .
